Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International journal of pharmaceutics

• Publication date

  2010-04-15

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.ijpharm.2010.01.012PMID 20083179PMCID PMC5831366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin.

  2009cited by this paper
• Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.

  2009cited by this paper
• Lipid nanocapsules: a new platform for nanomedicine.

  2009cited by this paper
• Cost-effectiveness of post-diagnosis treatment in dementia coordinated by multidisciplinary memory clinics in comparison to treatment coordinated by general practitioners: An example of a pragmatic trial

  2009cited by this paper
• Dementia

  2009cited by this paper
• Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.

  2008cited by this paper
• Enhanced oral delivery of antimony from meglumine antimoniate/beta-cyclodextrin nanoassemblies.

  2008cited by this paper
• Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-amyloid production

  2008cited by this paper
• Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis.

  2008cited by this paper
• Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable.

  2008cited by this paper
• Nanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution

  2008cited by this paper
• HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

  2008cited by this paper
• Intestinal efflux transport kinetics of green tea catechins in Caco‐2 monolayer model

  2007cited by this paper
• Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution.

  2007cited by this paper
• Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver, brain and small intestinal contents and in OptiMEM cell culture medium.

  2007cited by this paper
• Multi-component plasma quantitation of anti-hyperglycemic pharmaceutical compounds using liquid chromatography-tandem mass spectrometry.

  2007cited by this paper
• Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.

  2007cited by this paper
• Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers.

  2007cited by this paper
• Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.

  2007cited by this paper
• The coming problem of HIV-associated Alzheimer's disease.

  2007influential reference
• Peracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-Gallate

  2006cited by this paper
• Microglial cells in neurodegenerative disorders.

  2006influential reference
• Effect of piperine on the steady‐state pharmacokinetics of phenytoin in patients with epilepsy

  2006cited by this paper
• ADAM10 Activation Is Required for Green Tea (–)-Epigallocatechin-3-gallate-induced α-Secretase Cleavage of Amyloid Precursor Protein*

  2006cited by this paper
• Retrovirology BioMed Central Review HIV-1 associated dementia: symptoms and causes

  2006cited by this paper
• Metabolism of green tea catechins: an overview.

  2006cited by this paper
• Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs.

  2006cited by this paper
• EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.

  2006cited by this paper
• DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES

  2006cited by this paper
• Formulation of drugs in block copolymer micelles: drug loading and release.

  2006cited by this paper
• ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.

  2006cited by this paper
• Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice

  2005cited by this paper
• Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.

  2005cited by this paper
• Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers

  2004cited by this paper
• Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model.

  2004cited by this paper
• Rapid and sensitive liquid chromatography-tandem mass spectrometric method for the quantitation of metformin in human plasma.

  2004cited by this paper
• Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.

  2004cited by this paper
• Solid lipid nanoparticles for parenteral drug delivery.

  2004cited by this paper
• Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers.

  2004cited by this paper
• A Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers

  2003cited by this paper
• Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice.

  2003cited by this paper
• Cerebral pattern of pro- and anti-inflammatory cytokines in dementias.

  2003cited by this paper
• Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics.

  2002cited by this paper
• Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats.

  2002cited by this paper
• Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.

  2001cited by this paper
• The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

  2001cited by this paper
• Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry.

  2000cited by this paper
• Liposomal drug formulations. Rationale for development and what we can expect for the future.

  1998cited by this paper
• Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor.

  1998cited by this paper
• Liposome targeting to rat brain: effect of osmotic opening of the blood-brain barrier.

  1993cited by this paper
• Influence of piperine on rifampicin blood levels in patients of pulmonary tuberculosis.

  1985cited by this paper

• Harnessing Nature's Bounty: The Neuroprotective Potential of Phytoconstituents and Nanotechnology in Neurodegenerative Disease Therapeutics.

  2025cites this paper
• Lipid-Based Nanotechnologies for Delivery of Green Tea Catechins: Advances, Challenges, and Therapeutic Potential

  2025cites this paper
• Chemical and morphological analysis of permeable dentin exposed to experimental solutions containing epigallocatechin-3-gallate encapsulated in chitosan nanoparticles.

  2025cites this paper
• Comprehending Alzheimer's Disease: Molecular Mechanisms and Treatment Strategies.

  2025cites this paper
• Dietary Interventions in Neurodegenerative Diseases

  2025cites this paper
• Herbal Nanotechnology in Triple Negative Breast Cancer: A Comprehensive Review

  2025cites this paper
• Epigallocatechin 3-gallate-induced neuroprotection in neurodegenerative diseases: molecular mechanisms and clinical insights

  2025cites this paper
• Nanotherapeutic smart approaches for combating Alzheimer’s disease and overcoming existing obstacles: A novel eco-friendly green approach

  2025cites this paper
• Anti-cancer Properties of Epigallocatechin-3-gallate (EGCG) and its Signaling Pathways.

  2025cites this paper
• The green tea component (−)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells

  2025cites this paper
• Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases

  2024cites this paper
• Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases

  2024cites this paper
• Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention

  2024cites this paper
• Polyphenols and Their Biogenic Nano-Formulations Targeting BACE1 as Anti-Amyloid Therapies; Meeting the Challenges of Bioavailability, Safety, and Specificity for the Treatment of Alzheimer's Disease.

  2024cites this paper
• Herbal nanoparticles: a targeted approach for neurodegenerative disorder treatment

  2024cites this paper
• Effect of bioactive extracts from Eucalyptus globulus leaves in experimental models of Alzheimer's disease.

  2024cites this paper
• Epigallocatechin-3-gallate Loaded Proliposomal Vesicles for Management of Traumatic Brain Injury: In-vitro and In-vivo Evaluation

  2024cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• Nanotechnology in the diagnostic and therapy for Alzheimer's disease.

  2024cites this paper
• Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease

  2024cites this paper
• Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer's disease.

  2024cites this paper
• Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer’s Disease: Findings from Clinical Trials

  2024cites this paper
• Evaluation of the anti-depressant potential of EGCG-loaded nanoparticles in unstressed and stressed mice

  2024cites this paper
• Functional modification of recombinant brain-derived neurotrophic factor and its protective effect against neurotoxicity.

  2024cites this paper
• Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.

  2023cites this paper
• Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer’s disease in a rat/mouse model: a systematic review

  2023cites this paper
• Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases

  2023cites this paper
• Nature's Toolbox Against Tau Aggregation: An Updated Review of Current Research.

  2023cites this paper
• Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage

  2023cites this paper
• Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders

  2023cites this paper
• Cellular Stress Response (Hormesis) in Response to Bioactive Nutraceuticals with Relevance to Alzheimer Disease

  2023cites this paper
• Phytochemicals: A Promising Alternative for the Prevention of Alzheimer’s Disease

  2023cites this paper
• Flavonoids nanostructures promising therapeutic efficiencies in colorectal cancer.

  2023cites this paper
• Processing Technologies for the Extraction of Value-Added Bioactive Compounds from Tea

  2023cites this paper
• Research progress of EGCG in the treatment of Alzheimer's disease

  2022cites this paper
• Green tea improves cognitive function through reducing AD-pathology and improving anti-oxidative stress capacity in Chinese middle-aged and elderly people

  2022cites this paper
• Nanotherapeutics a promising approach for treatment of Parkinson’s disease

  2022cites this paper
• The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment

  2022cites this paper
• Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

  2022cites this paper
• Chemico-biological aspects of (−)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects

  2022influential citation
• Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases

  2022cites this paper
• A comprehensive review on the prevention and regulation of Alzheimer’s disease by tea and its active ingredients

  2022cites this paper
• Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy.

  2022cites this paper
• Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives

  2022cites this paper
• Technological and Biotechnological Processes To Enhance the Bioavailability of Dietary (Poly)phenols in Humans

  2022cites this paper
• Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases

  2022cites this paper
• Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration

  2022cites this paper
• Neuroprotective role of herbal alternatives in circumventing Alzheimer’s disease through multi-targeting approach - a review

  2022cites this paper
• Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality

  2022influential citation
• Strategies for the potential treatment of neurological disorders with Chinese and Indian medicinal plants

  2021cites this paper
• Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors.

  2021cites this paper
• Potential applications of nanomedicine for treating Parkinson's disease

  2021cites this paper
• Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases

  2021cites this paper
• Fabrication of chitosan-coated epigallocatechin-3-gallate (EGCG)-hordein nanoparticles and their transcellular permeability in Caco-2/HT29 cocultures.

  2021cites this paper
• Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease

  2021cites this paper
• Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems.

  2021cites this paper
• Neuroprotective Natural Products for Alzheimer’s Disease

  2021cites this paper
• Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity

  2021cites this paper
• Natural Products Targeting Amyloid Beta in Alzheimer’s Disease

  2021cites this paper
• Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

  2021cites this paper
• Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB

  2021cites this paper
• Alzheimer's disease and its treatment by different approaches: A review.

  2021cites this paper
• Effect of pH-shifting treatment on the structural and functional properties of soybean protein isolate and its interactions with (–)-epigallocatechin-3-gallate

  2021cites this paper
• Biocompatible, Antioxidant Nanoparticles Prepared from Natural Renewable Tea Polyphenols and Human Hair Keratins for Cell Protection and Anti-inflammation.

  2021cites this paper
• Molecular mechanisms of amyloid disaggregation

  2021cites this paper
• Phospholipid Based Nano Drug Delivery Systems of Phytoconstituents

  2021cites this paper
• Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges

  2021cites this paper
• Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

  2021cites this paper
• Nanomedicine against Alzheimer's and Parkinson's disease.

  2020cites this paper
• Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations

  2020cites this paper
• Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action

  2020cites this paper
• Polyphenol-Functionalized Plant Viral-Derived Nanoparticles Exhibit Strong Antimicrobial and Antibiofilm Formation Activities.

  2020cites this paper
• Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders

  2020cites this paper
• The Effects of Dietary Supplements That Overactivate the Nrf2/ARE System.

  2020cites this paper
• Role of flavonoids in neurodegenerative diseases: Limitations and future perspectives.

  2020cites this paper
• The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.

  2020cites this paper
• Differential scanning calorimetry (DSC) of nanoencapsulated food ingredients

  2020cites this paper
• Development and Optimization of Epigallocatechin-3-Gallate (EGCG) Nano Phytosome Using Design of Experiment (DoE) and Their In Vivo Anti-Inflammatory Studies

  2020cites this paper
• Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration.

  2020cites this paper
• The Potential Role of Natural Polyphenols Against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical studies.

  2020cites this paper
• Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases

  2020cites this paper
• Epigallocatechin-3-Gallate-Loaded Nanocarriers for Health Benefits

  2020cites this paper
• Extraction of catechins from green tea using supercritical carbon dioxide

  2020cites this paper
• Alzheimer’s disease: natural products as inhibitors of neuroinflammation

  2020cites this paper
• Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.

  2020cites this paper
• Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention

  2020influential citation
• Epigallocatechin-3-gallate in functional food development: From concept to reality

  2020cites this paper
• Lipid-Based Nano-delivery of Phytobioactive Compounds in Anti-aging Medicine

  2020cites this paper
• Nanoencapsulation of Green Tea Polyphenols

  2020cites this paper
• Nanocarriers as Tools for Delivery of Nature Derived Compounds and Extracts with Therapeutic Activity

  2020cites this paper
• Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.

  2020cites this paper
• Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach

  2020cites this paper
• Redox-Responsive Nanobiomaterials-Based Therapeutics for Neurodegenerative Diseases.

  2020cites this paper
• Nanomedicine for Bioactives: Healthcare applications

  2020cites this paper
• Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review

  2020cites this paper
• Additive-based stability assessment of biologically designed CuO and GSH-CuO nanospheres and their applicability as Nano-biosensors.

  2019cites this paper
• EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers

  2019cites this paper
• Fabrication of (-)-epigallocatechin-3-gallate carrier based on glycosylated whey protein isolate obtained by ultrasound Maillard reaction.

  2019cites this paper
• Nanobiotechnology in Neurodegenerative Diseases

  2019cites this paper
• Potential Treatment Strategies for the Treatment of Dementia With Chinese Medicinal Plants

  2019cites this paper